Navigation Links
BioStorage Technologies Appoints Dr. Wolfgang Hoffer as Managing Director of European Operations
Date:2/26/2008

INDIANAPOLIS, Feb. 26 /PRNewswire/ -- BioStorage Technologies, Inc. (BST), announces the appointment of Dr. Wolfgang Hoffer as Managing Director of the company's European operations in Griesheim, Germany. Hoffer joins BST with nearly 20 years of management experience in the fields of clinical pharmacology and toxicology. In his new role, Hoffer will report directly to James M. Saponaro, Chief Operating Officer for BST, and will manage all aspects of BST's Europe Division, including sales and marketing, operations and finance.

Dr. Hoffer has previously held positions with MOMENTUM Pharma Services, MDS Pharma Services, PAREXEL(R) International, The Boston Consulting Group and Solvay Pharma. Most recently, he was site director of MOMENTUM Pharma Services' Hamburg, Germany, location, following its spinout from MDS Pharma Services.

"Hoffer will focus on offering worldwide service to our global pharmaceutical clients while maintaining our standards of operational excellence," said F. John Mills, M.D., Ph.D., Chief Executive Officer and Chairman of the Board.

"We were looking for someone with broad, credible experience in the pharmaceutical and contract research industry. Not only does Wolfgang have the right level of industry experience and credentials, but he also has a first- rate, entrepreneurial spirit. We wanted someone who is willing to roll up his sleeves and get things done, and he is definitely that kind of individual," said Mills.

Dr. Hoffer holds a doctorate in physiological chemistry from the University of Veterinary Medicine Hannover (Germany), and is a certified veterinarian in the German state of Bavaria. Dr. Hoffer began his educational career studying chemistry and biology at the University of Kaiserslautern (Germany).

About BioStorage Technologies, Inc.:

BioStorage Technologies, Inc. is a worldwide leader in sample storage, inventory management and cold-chain logistics for the biotechnology and pharmaceuti
'/>"/>

SOURCE BioStorage Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. BioStorage Technologies Appoints Lori Ball as Vice President
2. BioStorage Technologies Becomes Green Powered through the Use of 100% Certified Renewable Energy
3. Neurobiological Technologies Announces Amendment of License and Cooperation Agreement with Merz Pharmaceuticals and Childrens Hospital
4. Microfluidic Systems Announces Agreements With Applied Biosystems and United Technologies Hamilton Sundstrand Division for Production of Bioagent Autonomous Networked Detector System
5. ImmunoVaccine Technologies appoints the Honourable Michael Kirby as Chair
6. Neurobiological Technologies Reports $2.1 Million Quarterly Payment for Sales of Memantine
7. NASA MidSTAR-1 successful technologies may be revolutionary
8. Senesco Technologies Reports Second Quarter Fiscal 2008 Financial Results
9. Neurobiological Technologies Sets Date for Research and Development Day
10. Neurobiological Technologies, Inc. (Nasdaq: NTII) Q2/08 Review Issued By Scimitar Equity Research, Inc.
11. Raven biotechnologies to Provide Updates on Oncology Pipeline With Four AACR Presentations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... ... August 27, 2015 , ... ... presented new data on the relationship of genetics and hypertension at the ... Heart Disease in Vancouver, British Columbia, Canada. The event, which boasts an extensive ...
(Date:8/26/2015)... 2015  The Diabetes Research Institute (DRI), a ... Miller School of Medicine, announced today that the ... for the first time a novel transplant technique ... approved Phase I/II study builds upon decades of ... important first step toward the development of the ...
(Date:8/26/2015)... After litigating and negotiating patent infringement ... P2i United States patent RE43,651 (the ... the United States without any admission or ... party. As a result of the parties, settlement, the US ... dismissed the case without prejudice. Under ...
(Date:8/25/2015)... and CARDIFF, UK (PRWEB) , ... August 25, ... ... and accurately determining whether breast tissue lesions are cancerous is described by University ... SPIE, the international society for optics and photonics. , In “ Breast cancer ...
Breaking Biology Technology:Proove Biosciences Presents Ground-Breaking Data on Genetics and Heart Disease at 20th World Congress on Heart Disease 2Proove Biosciences Presents Ground-Breaking Data on Genetics and Heart Disease at 20th World Congress on Heart Disease 3Diabetes Research Institute Successfully Transplants First Patient In Pilot BioHub Trial 2Diabetes Research Institute Successfully Transplants First Patient In Pilot BioHub Trial 3Diabetes Research Institute Successfully Transplants First Patient In Pilot BioHub Trial 4P2i Settles United States Litigation 2New Optical Method Promises Faster, More Accurate Diagnosis of Breast Cancer 2New Optical Method Promises Faster, More Accurate Diagnosis of Breast Cancer 3New Optical Method Promises Faster, More Accurate Diagnosis of Breast Cancer 4
... ROCKVILLE, Md., Aug. 24 /PRNewswire / --OriGene Technologies, ... representing the most comprehensive offering of human cell-produced human ... are purified from HEK293 cells transiently transfected with TrueORF ... to other expression systems in that it produces proteins ...
... BOZEN, Italy, August 24 Health ... recent partnership announcement with McKesson, it,has received categorical ... American,customers in just a few days since the ... prevent them from publicly,commenting on industry events, a ...
... SAN DIEGO, Aug. 24 Orexigen((R)) Therapeutics, Inc. (Nasdaq: ... joined the Company as Chief Commercial Officer. Mr. Booth ... to Orexigen. Most recently he served as President of ... commercial, medical and scientific affairs, business development and all support ...
Cached Biology Technology:Health Robotics Receives Overwhelming Support from its Customers for its McKesson-CytoCare Partnership 2Health Robotics Receives Overwhelming Support from its Customers for its McKesson-CytoCare Partnership 3Health Robotics Receives Overwhelming Support from its Customers for its McKesson-CytoCare Partnership 4Orexigen(R) Therapeutics Appoints Mark Booth Chief Commercial Officer 2
(Date:8/4/2015)... ALBANY, N.Y., Aug. 4, 2015  AMRI (NASDAQ: AMRI ) ... June 30, 2015. Highlights: , Second quarter ... increase from 2014 , Adjusted contract margins of ... EPS of $0.22, including a $0.05 decrease in EPS from royalties ... of $16 million "We are very pleased to ...
(Date:7/31/2015)... 31 de julho de 2015 A 10 ... ) será realizada pela BGI de 22-25 de outubro de ... A conferência está celebrando seu 10 o. ... ICG se tornou uma das reuniões mais influentes do ... científicos mais dinâmicos, entusiastas e prazerosos. ...
(Date:7/31/2015)... Conn. , Jul. 31, 2015 NXT-ID, Inc. ... biometric authentication company focused on the growing mobile commerce ... that it has filed provisional patent 62/198989 for ... This invention highlights a method to advance crypto-currencies such ... by introducing a common, uniform way to manage all ...
Breaking Biology News(10 mins):AMRI Announces Second Quarter 2015 Results 2AMRI Announces Second Quarter 2015 Results 3AMRI Announces Second Quarter 2015 Results 4AMRI Announces Second Quarter 2015 Results 5AMRI Announces Second Quarter 2015 Results 6AMRI Announces Second Quarter 2015 Results 7AMRI Announces Second Quarter 2015 Results 8AMRI Announces Second Quarter 2015 Results 9AMRI Announces Second Quarter 2015 Results 10AMRI Announces Second Quarter 2015 Results 11AMRI Announces Second Quarter 2015 Results 12AMRI Announces Second Quarter 2015 Results 13AMRI Announces Second Quarter 2015 Results 14AMRI Announces Second Quarter 2015 Results 15AMRI Announces Second Quarter 2015 Results 16AMRI Announces Second Quarter 2015 Results 17AMRI Announces Second Quarter 2015 Results 18AMRI Announces Second Quarter 2015 Results 19AMRI Announces Second Quarter 2015 Results 20AMRI Announces Second Quarter 2015 Results 21AMRI Announces Second Quarter 2015 Results 22AMRI Announces Second Quarter 2015 Results 23AMRI Announces Second Quarter 2015 Results 24A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 3NXT-ID Patents Electronic Crypto-Currency Management Technology 2NXT-ID Patents Electronic Crypto-Currency Management Technology 3NXT-ID Patents Electronic Crypto-Currency Management Technology 4
... pay attention in math class. Nature Communications ... how advanced mathematical modelling can be used in the ... and genetic modifications might allow cancer-killing, oncolytic viruses to ... stave off viral infection. "Oncolytic viruses are ...
... 2013)A new study shows that combining improved oyster restoration methods ... the oyster population back to the Bay in a much ... of the University of Maryland Center for Environmental Science,s Chesapeake ... to see which ones would have the most likelihood success. ...
... high risk for breast cancer, a long-term drug treatment can ... supported by the National Institutes of Health have now identified ... likely to benefit from this therapyand which should avoid it. ... individualized breast cancer prevention in women at high risk for ...
Cached Biology News:Using math to kill cancer cells 2Oysters could rebound more quickly with limited fishing and improved habitat 2Gene variants may predict who will benefit from breast cancer prevention drugs 2Gene variants may predict who will benefit from breast cancer prevention drugs 3
Human Cell Line Slides...
Human Cell Line Slides...
... Each Signet Level 2 Detection ... the avidin-biotin chemical bonding principle and ... to provide sensitivity, specificity and reliablility. ... immunostaining in both manual and automated ...
Mouse monoclonal [3576] to Yellow Fever Virus ( Abpromise for all tested applications). Antigen: Tissue / cell preparation...
Biology Products: